logo

PCV-16 Commercial-Scale cGMP Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Navi Mumbai, Maharashtra, India

Source: Voice Of HealthCare

Project
Awarded

The Technology Development Board (TDB), Department of Science & Technology, Government of India, has approved financial assistance to TechInvention Lifecare Limited, Navi Mumbai, for establishing a commercial-scale cGMP manufacturing facility for an indigenously developed 16-valent Pneumococcal Conjugate Vaccine (PCV-16). This project aims to strengthen India’s capability in next-generation conjug

Project Information FAQ

Project Information

4 Q
The project “PCV-16 Commercial-Scale cGMP Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Navi Mumbai, Maharashtra, India. Taiyo aggregates data on it from Voice Of HealthCare.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

awarded

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The Technology Development Board (TDB), Department of Science & Technology, Government of India, has approved financial assistance to TechInvention Lifecare Limited, Navi Mumbai, for establishing a commercial-scale cGMP manufacturing facility for an indigenously developed 16-valent Pneumococcal Conjugate Vaccine (PCV-16). This project aims to strengthen India’s capability in next-generation conjugate vaccines and reduce long-term reliance on imported products. Early-stage development took place at TechInvention’s BSL-2 facility at RCB Faridabad and the GMP-aligned R&D centre 'HORIZON' in Navi Mumbai. The programme will transition to full-scale cGMP manufacturing to develop, validate, and commercialise advanced conjugate vaccine technologies domestically, boosting vaccine self-reliance and expanding local biomanufacturing capacity.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data